Departed
Catherine Owen
Director
OptiNose, Inc.
Ms. Catherine Owen resigned from the Board of Directors of OptiNose, Inc. (the "Company") on September 24, 2024.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6651–6700 of 75417
Departed
Eric Floyd
Chairman of the Board
Virpax Pharmaceuticals, Inc.
On September 20, 2024, Eric Floyd, Chairman of the Board, notified the Company of his intention to resign from the Board, effective immediately.
Departed
Seth Schorr
Board of Directors
SKLZ ·
Skillz Inc.
On September 19, 2024, Seth Schorr informed Skillz Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors (the “Board”), effective immediately.
Departed
Paul Carl “Chip” Schorr IV
Director
ALGM ·
ALLEGRO MICROSYSTEMS, INC.
Paul Carl “Chip” Schorr IV notified the Board of his decision to resign from the Board and as a member of the Board’s Strategy Committee, effective September 20, 2024.
Departed
Gregory C. Pitts
Executive Vice President and Chief Operating Officer
PRI ·
Primerica, Inc.
informed the Company’s Chief Executive Officer of Mr. Pitts’ intention to retire on or about April 1, 2025.
Departed
Erik Gershwind
President
MSM ·
MSC INDUSTRIAL DIRECT CO INC
Erik Gershwind, who has voluntarily resigned as President, effective September 23, 2024.
Departed
Michael J. Kavanagh
Executive Vice President and Chief Operating Officer–Towers
CCI ·
CROWN CASTLE INC.
On September 23, 2024, Crown Castle Inc. ("Company") was notified by Michael J. Kavanagh, its Executive Vice President ("EVP") and Chief Operating Officer ("COO")–Towers, that he has elected to retire from the Company.
Departed
Brian M. Larkin
Director
DYNATRONICS CORP
On September 23, 2024, Brian M. Larkin tendered his resignation as a director of Dynatronics Corporation (the "Company") to the Company's Board of Directors (the "Board").
Departed
Michael Miller
Executive Vice President, Corporate Development & Affairs, Chief Legal Officer and Secretary
BNED ·
Barnes & Noble Education, Inc.
On September 23, 2024, Michael Miller provided notice of his resignation as the Company’s Executive Vice President, Corporate Development & Affairs, Chief Legal Officer and Secretary, effective immediately.
Departed
Lyle Logan
Director
HEIDRICK & STRUGGLES INTERNATIONAL INC
On September 19, 2024, Lyle Logan notified the Board that he would resign as a member of the Board, effective upon the adjournment of the Board meeting on September 26, 2024.
Departed
Jeffrey Friedman
Chief Financial Officer
VEEA ·
VEEA INC.
Effective September 13, 2024, Jeffrey Friedman resigned as Senior Vice President and Chief Financial Officer of the Company.
Departed
Stephen LaMarche
Chief Operations Officer
HWNI ·
HIGH WIRE NETWORKS, INC.
On September 19, 2024, Stephen LaMarche, the former Chief Operations Officer of High Wire Networks, Inc. (the “Company”), resigned from his position with the Company.
Departed
Shawn Dym
Member of the Board and Chair of the Audit Committee
SBIG ·
SpringBig Holdings, Inc.
Effective at 12 noon on September 23, 2024, Mr. Dym resigned as a member of the Board, including as Chair of the Audit Committee.
Departed
Rob Wiley
Chief Financial Officer
POWW ·
Outdoor Holding Co
On September 19, 2024, the Company received a notice of resignation from its Chief Financial Officer, Rob Wiley, effective September 20, 2024.
Departed
Gregory H. Trepp
Chief Executive Officer
HBB ·
Hamilton Beach Brands Holding Co
On September 20, 2024, Gregory H. Trepp, the Chief Executive Officer and a member of the Board of Directors (the “Board”) of Hamilton Beach Brands Holding Company (the “Company”), informed the Company of his intention to retire on December 31, 2024, indicating that he has decided to resign as Chief Executive Officer of the Company and as a member of the Board, effective September 30, 2024
Departed
Jeffrey Perez
Senior Vice President, Intellectual Property Affairs
PGEN ·
PRECIGEN, INC.
On September 23, 2024, Precigen, Inc. (the “Company”) announced the separation from employment of Jeffrey Perez, Senior Vice President, Intellectual Property Affairs, effective November 1, 2024.
Departed
Terry Pennington
Chief Revenue Officer
EBF ·
ENNIS, INC.
On September 20, 2024, Terry Pennington, Chief Revenue Officer announced his retirement from the Company, effective February 28, 2025.
Departed
Ronald M. Graham
Vice President - Administration
EBF ·
ENNIS, INC.
On September 20, 2024, Ronald M. Graham, Vice President - Administration announced his retirement from Ennis, Inc. (the “Company”), effective February 28, 2025.
Departed
Jeffrey L. Edwards
Director
LFCR ·
LIFECORE BIOMEDICAL, INC. DE
Jeffrey L. Edwards notified Lifecore Biomedical, Inc. (the “Company”) that he has elected not to stand for re-election to serve as a director of the Board of Directors of the Company (the “Board”) at the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”)
Departed
Ray Diradoorian
Director
LFCR ·
LIFECORE BIOMEDICAL, INC. DE
Ray Diradoorian notified the Company that he intends to resign as a director of the Board effective as of immediately prior to the Annual Meeting.
Departed
Teresa Barger
Independent Director
IXAQF ·
IX Acquisition Corp.
Teresa Barger Independent Director, Member of Audit Committee and Compensation Committee
Departed
Karen Bach
Chief Executive Officer
IXAQF ·
IX Acquisition Corp.
Karen Bach Chief Executive Officer and Director
Departed
Andrew Bartley
Independent Director
IXAQF ·
IX Acquisition Corp.
Andrew Bartley Independent Director, Chair of Audit Committee and Member of Compensation Committee
Departed
Guy Willner
Executive Chairman
IXAQF ·
IX Acquisition Corp.
Guy Willner Executive Chairman and Director
Departed
Dr. Jay Varma
Director
SIGA ·
SIGA TECHNOLOGIES INC
Pursuant to the terms of his employment agreement, Dr. Varma’s service on the Company’s Board of Directors also automatically ended effective immediately.
Departed
Dr. Jay Varma
Executive Vice President and Chief Medical Officer
SIGA ·
SIGA TECHNOLOGIES INC
On September 23, 2024, the Board of Directors of SIGA Technologies, Inc. (the “Company”) terminated Dr. Jay Varma, effective immediately, other than for cause, from his position as Executive Vice President and Chief Medical Officer of the Company.
Departed
Stephen R. Davis
President and Chief Executive Officer
ACAD ·
ACADIA PHARMACEUTICALS INC
Stephen R. Davis is departing the Company and will be succeeded by Catherine Owen Adams.
Departed
Richard Noll
Director and non-executive Chairman
REYN ·
Reynolds Consumer Products Inc.
On September 18, 2024, Richard Noll, a director of the Company, notified the Company of his decision to resign as a director of the Company, effective immediately.
Departed
Charles R. Carter
Chief Financial Officer
CERO ·
CERO THERAPEUTICS HOLDINGS, INC.
On September 17, 2024, the Chief Financial Officer of CERo Therapeutics Holdings, Inc. (the “ Company ”), Charles R. Carter, informed the Board of Directors of the Company (the “ Board ”) that he expects to accept a new position with another publicly-traded company.
Departed
Kenny Young
President
RILY ·
BRC Group Holdings, Inc.
On September 20, 2024, Kenny Young resigned from his positions as the President of the Company, the Chief Executive Officer of B. Riley Principal Investments, LLC, and other officer roles at certain other Company subsidiaries.
Departed
David J. Mehok
Chief Financial Officer
QTWO ·
Q2 Holdings, Inc.
Mr. Mehok’s departure is not due to any dispute or disagreement with Q2 on any matter relating to Q2’s operations, policies, practices or financial performance.
Departed
Janet Hall
President and Chief Executive Officer
Guardion Health Sciences, Inc.
On September 17, 2024, Guardion Health Sciences, Inc. (the “Company”) announced the termination of Janet (“Jan”) Hall, its President and Chief Executive Officer, effective on October 17, 2024.
Departed
Mihir Shah
Chief Financial Officer
TOI ·
Oncology Institute, Inc.
On September 19, 2024, Mihir Shah, the Chief Financial Officer, principal financial officer, and principal accounting officer of The Oncology Institute, Inc. (the “Company”), delivered a notice of resignation effective as of October 14, 2024.
Departed
Ian Goodkind
Chief Financial Officer
Jamf Holding Corp.
Mr. Rudow will begin employment with the Company on October 28, 2024 and will succeed Mr. Goodkind as the Company’s new Chief Financial Officer, effective November 28, 2024.
Departed
Theodore Colbert III
President and Chief Executive Officer of Boeing Defense, Space & Security
BA ·
BOEING CO
Theodore Colbert III ceased to serve as an elected officer of The Boeing Company and as President and Chief Executive Officer of Boeing Defense, Space & Security, effective September 20, 2024.
Departed
Wendy Watson
Director
CFG ·
CITIZENS FINANCIAL GROUP INC/RI
The Company also announced that Wendy Watson will retire from the Board after her current term expires at the annual meeting of shareholders in April 2025.
Departed
Michael J. Quinn
President and Chief Executive Officer
RBKB ·
Rhinebeck Bancorp, Inc.
On September 17, 2024, the Board of Directors of Rhinebeck Bank, the wholly owned subsidiary of Rhinebeck Bancorp, Inc., provided notice of non-renewal to each of Michael J. Quinn, President and Chief Executive Officer, and Jamie J. Bloom, EVP, Chief Operating Officer & Chief Banking Officer, under each individual’s Amended and Restated Employment Agreement.
Departed
Jamie J. Bloom
EVP, Chief Operating Officer & Chief Banking Officer
RBKB ·
Rhinebeck Bancorp, Inc.
On September 17, 2024, the Board of Directors of Rhinebeck Bank, the wholly owned subsidiary of Rhinebeck Bancorp, Inc., provided notice of non-renewal to each of Michael J. Quinn, President and Chief Executive Officer, and Jamie J. Bloom, EVP, Chief Operating Officer & Chief Banking Officer, under each individual’s Amended and Restated Employment Agreement.
Departed
Hunter R. Greenlaw, Jr.
member of the board of directors
OLD DOMINION ELECTRIC COOPERATIVE
As a result, Mr. Greenlaw ceased to serve as a member of the Old Dominion Electric Cooperative board of directors on such date.
Departed
Daniel N. Swisher Jr.
Member of the Board of Directors
PTGX ·
Protagonist Therapeutics, Inc
On September 17, 2024, Daniel N. Swisher Jr., a member of the Board of Directors (the “Board”) of Protagonist Therapeutics, Inc. (the “Company”) and a member of the Audit Committee of the Board, resigned from the Board, effective September 17, 2024.
Departed
Erik Mickelson
Chief Accounting Officer
Paragon 28, Inc.
Erik Mickelson has stepped down as Chief Accounting Officer of Paragon 28, Inc.
Departed
Jay K. Varma
Executive Vice President and Chief Medical Officer
SIGA ·
SIGA TECHNOLOGIES INC
On September 19, 2024, Dr. Jay K. Varma began an indefinite leave of absence from his positions as Executive Vice President and Chief Medical Officer of SIGA Technologies, Inc. (the “Company”) and as a member of the Board of Directors of the Company.
Departed
Jay K. Varma
Member of the Board of Directors
SIGA ·
SIGA TECHNOLOGIES INC
On September 19, 2024, Dr. Jay K. Varma began an indefinite leave of absence from his positions as Executive Vice President and Chief Medical Officer of SIGA Technologies, Inc. (the “Company”) and as a member of the Board of Directors of the Company.
Departed
Debby Soo
Director
EVCM ·
EverCommerce Inc.
On September 19, 2024, Debby Soo resigned from the Board, effective October 31, 2024.
Departed
Marie Myers
Director
KLAC ·
KLA CORP
On September 16, 2024, Marie Myers, a member of the Board of Directors (the “Board”) of KLA Corporation (the “Company”), notified the Company that she will not stand for reelection to the Board at the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”), and therefore her term as a director will end at the Annual Meeting.
Departed
L. Denise Williams
Chief People Officer
FIS ·
Fidelity National Information Services, Inc.
Ms. Williams will continue to serve as the Company’s Chief People Officer through December 31, 2024.
Departed
(interim)
David Gaiero
interim principal financial officer and principal accounting officer
SNSE ·
Sensei Biotherapeutics, Inc.
In connection with such appointment, David Gaiero, who was serving as the Company’s principal financial officer and principal accounting officer on an interim basis, ceased serving in such capacities as of the Effective Date.
Departed
Lawrence Eichenfield
Director
FBRX ·
Forte Biosciences, Inc.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
Departed
Donald A. Williams
Director
FBRX ·
Forte Biosciences, Inc.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
Departed
Eric B. Staves
Vice President, Corporate Controller
CNMD ·
CONMED Corp
On September 16, 2024, Eric B. Staves, Vice President, Corporate Controller, informed CONMED Corporation (the “Company”) that, effective September 27, 2024, he plans to leave the Company to pursue an executive opportunity.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.